Both in Biotechnology
Eikon Therapeutics vs X4 Pharmaceuticals
Over the past year EIKN returned −59.9% and XFOR returned −12.4%; their daily moves had a correlation of 0.28.
EIKN −59.9% XFOR −12.4%Growth of $1, one year, split-adjusted
| Metric | EIKN | XFOR |
|---|---|---|
| Price | $5.55 | $3.17 |
| Market cap | $300.6M | $314.3M |
| Today | −2.29% | −5.37% |
| 1 month | −26.4% | +9.3% |
| 6 months | −46.0% | −24.5% |
| Year to date | — | −20.8% |
| 1 year | — | −21.5% |
| Revenue growth (YoY) | — | +346.3% |
| Gross margin | — | 81.6% |
| Net margin | — | −183.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 19.8× |
| Net cash | $531.2M | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | 99.9% | 60.7% |
| Short % of float | 20.4% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).